HOME >> BIOLOGY >> NEWS
How the Biotech Revolution Is Changing the Way We Fight Disease

In the fall of 2005, leading scientists from the National Cancer Institute announced the beginning of the cancer genome atlas project, a large-scale endeavor to map every gene implicated in cancer and the first step toward development of new therapies for treating this still baffling disease. This spin-off of the human genome project is only the latest exciting research advance in a decades-long quest to fully understand the biochemistry of the human body and thereby gain insights into the secrets of health, disease, and aging.

In the new book DNA: How the Biotech Revolution Is Changing the Way We Fight Disease (Prometheus Books, $26) biochemist and veteran lab researcher Frank H. Stephenson tells the compelling story of how scientists on many fronts are succeeding in the battle against disease.

According to Stephenson, efforts to understand the nature of disease, down to its component molecular foundation, have reached an unprecedented intensity. There is an excitement out there, an expectation, that we are but a little ways away from stopping cancer in its tracks, from curing diabetes, and from preventing afflictions such as Alzheimer's, AIDS, and malaria, he says. There is the sense that each gene we discover, each molecular pathway we elucidate brings us closer to cures.

With a gift for making the complexities of genetics and biochemistry understandable to the average reader, Stephenson offers a fascinating tour of the mechanisms of our body and the therapeutic techniques that are gaining in sophistication and effectiveness every year. From heart disease to AIDS and cancer, he helps you understand how the tools of biotechnology are being used to combat our most common afflictions. Stephenson examines a wide variety of health threats and illnesses: HIV infection, the many forms of cancer, asthma, diabetes, Alzheimers, obesity, and even erectile dysfunction. Each is discussed in terms of its root cause and treatment in pla
'"/>

Contact: Lynn Pasquale
Lpasquale@prometheusbooks.com
800-853-7545
Prometheus Books
18-Jun-2007


Page: 1 2

Related biology news :

1. Biotech breakthrough could end biodiesels glycerin glut
2. Rutgers: GM/GMO/Biotech crop containment strategy
3. Ronald Cape to receive 2007 Biotechnology Heritage Award
4. Oncolytics Biotech Inc., research collaborators demonstrate reovirus/gemcitabine
5. Oncolytics Biotech Inc. proceeds to initiate US Phase II sarcoma clinical trial
6. Biotechnology Study Center honors Joan V. Ruderman, Salvador Moncada and Charles N. Serhan
7. European Federation of Biotechnology and Elsevier announce launch of biotechnology journal
8. Advances in Optics for Biotechnology, Medicine and Surgery
9. Biolex reports potential for more potent, efficacious antibodies in Nature Biotechnology
10. Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry
11. Biotech cotton provides same yield with fewer pesticides

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: How the Biotech Revolution Changing the Way Fight Disease

(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
(Date:8/4/2015)...  Blueprint Medicines (NASDAQ: BPMC ), a leader ... genomically defined diseases, today announced that Jeffrey Albers ... at the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, ... A live webcast of the event will be available ... website at www.blueprintmedicines.com . An archived replay of ...
(Date:8/4/2015)... Aug. 4, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it ... quarter, ended June 30, 2015, after market close on ... call on Thursday, August 13, 2015, at 8:00 a.m. ... Standard Time) to review the Company,s financial results and ...
(Date:8/3/2015)... Aug. 3, 2015  MiMedx Group, Inc. (NASDAQ: ... amniotic tissue and patent-protected processes to develop and market ... Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of ... 35 th Annual Canaccord|Genuity Growth Conference in ... Chairman and CEO, William C. Taylor , President ...
(Date:8/3/2015)... 2015  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... life-threatening diseases, today announced that it will host its ... on Thursday, August 13, 2015 at 4:30 p.m. Eastern ... the release of fiscal 2016 first quarter results.  A ... two hours after the call at the Investor Relations ...
Breaking Biology Technology:Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2
Cached News: